PAVM - PAVmed Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-85,741
-88,983
-50,347
-34,276
-16,457
Depreciation & amortisation
1,897
2,457
226
23
14.226
Stock-based compensation
18,963
19,532
15,009
2,044
1,571
Change in working capital
-4,348
-716
-1,566
83
-63.934
Accounts receivable
169
183
-200
-
-
Accounts payable
-3,718
-742
174
501
613.283
Other working capital
-73,458
-72,525
-42,060
-21,969
-13,384
Other non-cash items
5,771
5,546
-1,549
5,327
558.599
Net cash provided by operating activities
-70,939
-70,985
-40,591
-21,914
-13,357
Cash flows from investing activities
Investments in property, plant and equipment
-2,519
-1,540
-1,469
-55
-27.203
Acquisitions, net
-5,300
-3,200
-2,247
-
-
Net cash used for investing activities
-7,819
-4,740
-3,716
-55
-27.203
Cash flows from financing activities
Debt repayment
0
0
-14,970
-600
-364.752
Common stock issued
63,916
1,886
117,016
16,032
5,547
Common stock repurchased
-366
-366
-
-
-
Dividends paid
-
-
-
-
0
Other financing activities
-
-
-6,977
-100
-101.098
Net cash used provided by (used for) financing activities
98,202
38,211
104,309
33,006
11,382
Net change in cash
19,444
-37,514
60,002
11,037
-2,003
Cash at beginning of period
37,341
77,258
17,256
6,219
8,222
Cash at end of period
56,785
39,744
77,258
17,256
6,219
Free cash flow
Operating cash flow
-70,939
-70,985
-40,591
-21,914
-13,357
Capital expenditure
-2,519
-1,540
-1,469
-55
-27.203
Free cash flow
-73,458
-72,525
-42,060
-21,969
-13,384